Addressing cardiometabolic risk during treatment with antipsychotic medications.

  title={Addressing cardiometabolic risk during treatment with antipsychotic medications.},
  author={Jonathan M. Amiel and Christina V Mangurian and Rohan Ganguli and John W. Newcomer},
  journal={Current opinion in psychiatry},
  volume={21 6},
PURPOSE OF REVIEW To raise awareness of and inform evidence-based practice regarding medical and behavioral interventions for antipsychotic medication-induced metabolic abnormalities. RECENT FINDINGS The current literature indicates that individuals with severe and persistent mental illness have significantly worse health outcomes and premature mortality than the general population, owing to a combination of under-recognition and treatment of medical risk factors, reduced access to care… CONTINUE READING